Abstract
A major factor limiting the development and approval for human use of DNA vaccines is the lack of an ideal vector for gene delivery that is both efficient and safe. Although safer, non-viral vectors face a number of physical, enzymatic and diffusional barriers that limit the delivery of transgenes to the nucleus of the target cells. These limitations are even more important when it comes …